Carol R. Lizak is CFO at Jaguar Health, Inc. (JAGX). They have made 1 open-market trade across 1 company since 2021, most recently 2025-12-11.
CIK 0001785794
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $20K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| JAGX | 11,911 | $42K |
Shares reported on the most recent Form 4, priced at the 2025-12-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAGX | BUY | 2021-09-13 | 2022-03-30 | $2.51 | $20K | -10.9% | -27.5% | -49.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.